Quantbot Technologies LP Has $738,000 Position in Astrana Health, Inc. $ASTH

Key Points

• Quantbot Technologies LP significantly increased its stake in Astrana Health, raising its holdings by 123.5% to a total value of $738,000 according to its latest SEC filing.
• Astrana Health reported $0.19 EPS for the last quarter, missing analysts' estimates of $0.36 EPS, despite achieving revenue of $654.81 million.
• The company's stock has shown volatility, with a one-year low of $21.20 and a high of $63.20, currently trading at $30.68.

Quantbot Technologies LP lifted its stake in shares of Astrana Health, Inc. (NASDAQ:ASTH - Free Report) by 123.5% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 23,806 shares of the company's stock after acquiring an additional 13,155 shares during the period. Quantbot Technologies LP's holdings in Astrana Health were worth $738,000 at the end of the most recent quarter.

Other large investors also recently made changes to their positions in the company. Two Sigma Investments LP bought a new stake in shares of Astrana Health during the fourth quarter worth $466,000. Wells Fargo & Company MN increased its position in shares of Astrana Health by 41.5% during the fourth quarter. Wells Fargo & Company MN now owns 22,484 shares of the company's stock worth $709,000 after acquiring an additional 6,596 shares in the last quarter. Dimensional Fund Advisors LP increased its position in shares of Astrana Health by 10.7% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,045,540 shares of the company's stock worth $32,968,000 after acquiring an additional 101,192 shares in the last quarter. First Trust Advisors LP increased its position in shares of Astrana Health by 702.6% during the fourth quarter. First Trust Advisors LP now owns 107,343 shares of the company's stock worth $3,385,000 after acquiring an additional 93,969 shares in the last quarter. Finally, Hussman Strategic Advisors Inc. increased its position in shares of Astrana Health by 33.3% during the first quarter. Hussman Strategic Advisors Inc. now owns 84,000 shares of the company's stock worth $2,605,000 after acquiring an additional 21,000 shares in the last quarter. Institutional investors own 52.77% of the company's stock.

Astrana Health Stock Up 2.0%

Astrana Health stock traded up $0.63 during mid-day trading on Friday, reaching $31.96. The company's stock had a trading volume of 358,021 shares, compared to its average volume of 501,014. The company has a market capitalization of $1.79 billion, a price-to-earnings ratio of 62.67, a price-to-earnings-growth ratio of 0.79 and a beta of 0.85. Astrana Health, Inc. has a 12 month low of $21.20 and a 12 month high of $63.20. The business's 50 day simple moving average is $25.91 and its 200 day simple moving average is $28.41. The company has a debt-to-equity ratio of 0.52, a quick ratio of 1.59 and a current ratio of 1.59.

Astrana Health (NASDAQ:ASTH - Get Free Report) last released its earnings results on Thursday, August 7th. The company reported $0.19 earnings per share for the quarter, missing analysts' consensus estimates of $0.36 by ($0.17). The business had revenue of $654.81 million during the quarter, compared to the consensus estimate of $639.13 million. Astrana Health had a net margin of 1.04% and a return on equity of 3.43%. The firm's revenue for the quarter was up 34.7% on a year-over-year basis. During the same period last year, the business posted $0.40 EPS. Astrana Health has set its Q3 2025 guidance at EPS. As a group, research analysts anticipate that Astrana Health, Inc. will post 1.15 earnings per share for the current year.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.